Fujifilm of Japan is about to boost production of a drug to treat Ebola fever. Wall Street Journal states that product in an equivalent of 20 thousand full course treatments as well as 300 thousand more worth of API will be produced. The aniviral drug Avigan (favipiravir) has been approved by the Japanese government for disease treatment, but it is currently only been licensed to treat influenza by regulatory authorities. Pilot clinical trials in patients with Ebola launch in Guinea in November. According to WHO, the tall from the disease reached 4 922 out of over 10 000 infected in 8 countries on October 25. EvaluatePharma® forecasts Ebola treatment drug market to reach 151 mln USD by 2020.

Sources: Pharmvestnik, Reuters, WHO, EvaluatePharma®